Edition:
India

Organovo Holdings Inc (ONVO.OQ)

ONVO.OQ on NASDAQ Stock Exchange Global Market

1.52USD
24 Nov 2017
Change (% chg)

$0.01 (+0.66%)
Prev Close
$1.51
Open
$1.50
Day's High
$1.52
Day's Low
$1.47
Volume
100,085
Avg. Vol
210,044
52-wk High
$4.07
52-wk Low
$1.33

Chart for

About

Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products,... (more)

Overall

Beta: 3.21
Market Cap(Mil.): $215.48
Shares Outstanding(Mil.): 105.63
Dividend: --
Yield (%): --

Financials

BRIEF-Organovo posts Q3 loss per share $0.09

* Organovo announces fiscal second-quarter 2018 results; company shifts commercial focus to higher-value disease modeling opportunities and updates full-year fiscal 2018 outlook

10 Nov 2017

BRIEF-Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease

* Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease

06 Nov 2017

BRIEF-Organovo reports Q1 loss per share $0.10

* Organovo announces fiscal first-quarter 2018 results; company affirms full-year fiscal 2018 outlook

10 Aug 2017

Earnings vs. Estimates